Newborn babies have one of three pioneer bacteria in their gut shortly after birth, one of which could be used to develop new personalized infant therapeutic probiotics, researchers show.
As Congress debates orphan reforms, new analysis finds 65% of orphan drugs approved for a single rare disease
As Congress considers whether to shift away from orphan drug incentives that have provided a windfall for industry in some cases, a new FDA and
January 10, 2024